211 related articles for article (PubMed ID: 13735975)
1. [Metabolism of iron and copper, action of chelators and therapeutic possibilities in Wilson's disease and hemochromatosis].
PIRART J
Pathol Biol; 1961 May; 9():1157-74. PubMed ID: 13735975
[No Abstract] [Full Text] [Related]
2. [Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
Petera V; Lahn V; Virt S; Voleníková L; Kohout J
Z Gesamte Inn Med; 1969 May; 24(10):315-9. PubMed ID: 5807434
[No Abstract] [Full Text] [Related]
3. Hereditary iron and copper deposition: diagnostics, pathogenesis and therapeutics.
Aaseth J; Flaten TP; Andersen O
Scand J Gastroenterol; 2007 Jun; 42(6):673-81. PubMed ID: 17505988
[TBL] [Abstract][Full Text] [Related]
4. Current and future therapy in haemochromatosis and Wilson's disease.
Murray KF; Lam D; Kowdley KV
Expert Opin Pharmacother; 2003 Dec; 4(12):2239-51. PubMed ID: 14640923
[TBL] [Abstract][Full Text] [Related]
5. Iron accumulation in the liver of male patients with Wilson's disease.
Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary Liver Diseases: Wilson's Disease and Hemochromatosis].
Merle U; Mohr I
Dtsch Med Wochenschr; 2023 Jul; 148(13):836-843. PubMed ID: 37364578
[TBL] [Abstract][Full Text] [Related]
7. Genetic hemochromatosis and Wilson's disease: role for oxidant stress?
Britton RS; Brown KE
Hepatology; 1995 Apr; 21(4):1195-7. PubMed ID: 7705796
[No Abstract] [Full Text] [Related]
8. Copper metabolism in Wilson's disease, Laennec's cirrhosis and hemachromatosis: studies with radiocopper (Cu64).
MAYTUM WJ; GOLDSTEIN NP; McGUCKIN WF; OWEN CA
Proc Staff Meet Mayo Clin; 1961 Dec; 36():641-60. PubMed ID: 14471779
[No Abstract] [Full Text] [Related]
9. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
10. [Liver cirrhosis in primary hemochromatosis and Wilson's disease].
Kobune M; Kato J; Kohgo Y; Niitsu Y
Nihon Rinsho; 1994 Jan; 52(1):209-14. PubMed ID: 8114295
[TBL] [Abstract][Full Text] [Related]
11. The action of chelating agents in Wilson's disease.
HILL L; WALSHE JM
Lancet; 1959 Sep; 2(7100):444-5. PubMed ID: 13852382
[No Abstract] [Full Text] [Related]
12. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis.
Nair J; Carmichael PL; Fernando RC; Phillips DH; Strain AJ; Bartsch H
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):435-40. PubMed ID: 9610794
[TBL] [Abstract][Full Text] [Related]
13. The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.
Dusek P; Roos PM; Litwin T; Schneider SA; Flaten TP; Aaseth J
J Trace Elem Med Biol; 2015; 31():193-203. PubMed ID: 24954801
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease.
Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
[TBL] [Abstract][Full Text] [Related]
16. Excessive iron storage in a patient with Wilson's disease.
Hafkemeyer P; Schupp M; Storch M; Gerok W; Häussinger D
Clin Investig; 1994 Jan; 72(2):134-6. PubMed ID: 8186659
[TBL] [Abstract][Full Text] [Related]
17. [Ceruloplasmine and iron metabolism: their implications in hemochromatosis, Wilson's disease and aceruloplasminemia].
Pérez-Aguilar F
Rev Clin Esp; 2002 Dec; 202(12):649-51. PubMed ID: 12459093
[No Abstract] [Full Text] [Related]
18. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
19. [Significance of the iron and copper content of the liver for the differential diagnosis of chronic liver diseases].
Schwabe U; Friedrich K
Z Gastroenterol; 1990 Jul; 28(7):353-7. PubMed ID: 2238766
[TBL] [Abstract][Full Text] [Related]
20. Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
Harada M; Miyagawa K; Honma Y; Hiura M; Shibata M; Matsuhashi T; Abe S; Harada R; Tabaru A
Intern Med; 2011; 50(14):1461-4. PubMed ID: 21757830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
